South & Central America Pharmaceutical Excipients Market is expected to reach US$ 597.5 Million by 2034

According to The Insight Partners' research, the South and Central America Pharmaceutical Excipients Market was valued at US$ 362.2 Million in 2025 and is expected to reach US$ 597.5 Million by 2034, registering a CAGR of 5.8% from 2026 to 2034.

Growing advancements in multifunctional and nanotechnology excipients and rising adoption of biologics and novel delivery systems are among the critical factors attributed to drive the South & Central America pharmaceutical excipients market.

In the market, advancements in multifunctional and nanotechnology excipients are paving the way for more sophisticated drug formulations that enhance stability, bioavailability, and targeted delivery. Multifunctional excipients, which combine multiple roles such as solubilization, lubrication, and controlled release within a single material, streamline manufacturing processes and reduce the need for multiple additives, leading to cleaner and more efficient formulations. Lipid-based multifunctional excipients such as self-emulsifying drug delivery systems (SEDDS) are used in oral tablets for poorly water-soluble drugs, allowing for rapid dispersion in the gastrointestinal tract and improved absorption of compounds such as itraconazole. Nanotechnology takes this by engineering excipients at the nanoscale, where particles exhibit unique properties such as high surface area and tunable porosity. Nano-sized excipients, such as polymeric nanoparticles derived from chitosan or silica, enable precise encapsulation of active pharmaceutical ingredients (APIs), protecting them from degradation and facilitating site-specific release. A notable example is the use of lipid nanoparticles in mRNA vaccines, where excipients such as ionizable lipids not only stabilize the genetic material but also promote endosomal escape for effective cellular uptake. These innovations address challenges in treating hydrophobic drugs and biologics, offering enhanced therapeutic outcomes with minimal side effects. As regulatory bodies embrace these technologies, pharmaceutical companies are exploring hybrid excipients that integrate nanotechnology with natural polymers, such as cellulose nanocrystals modified for mucoadhesive properties in nasal sprays for Alzheimer's therapeutics. This shift not only optimizes drug performance but also supports sustainable practices by reducing excipient quantities. These advancements promise to transform chronic disease management, from oncology to cardiology, by enabling excipients that adapt to physiological conditions, fostering a more patient-centric pharmaceutical landscape.

On the contrary, stringent and complex regulatory frameworks hamper the growth of the South & Central America pharmaceutical excipients market.

South and Central America Pharmaceutical Excipients Market Segmentation Analysis:

• By Type, the South and Central America Pharmaceutical Excipients Market is segmented into Bioresorbable Polymers and Lipids and Liposome Based Formulation, Oleochemicals, Sugars, Cellulose, Starches, Petrochemicals, Plant Proteins Polyols and Cyclodextrins, Inorganic Chemicals, and Others. The Cellulose segment is projected to expand at a CAGR of 5.6% during 2026 - 2034.
• By Oleochemicals For Type, the South and Central America Pharmaceutical Excipients Market is segmented into Fatty Alcohols, Metal Stearates, Glycerin, and Other Oleochemicals. The Fatty Alcohols segment is projected to expand at a CAGR of 6.3% during 2026 - 2034.
• By Sugars For Type, the South and Central America Pharmaceutical Excipients Market is segmented into Actual Sugars, Sugar Alcohols, and Artificial Sweeteners. The Actual Sugars segment is projected to expand at a CAGR of 4.9% during 2026 - 2034.
• By Cellulose For Type, the South and Central America Pharmaceutical Excipients Market is segmented into Microcrystalline Cellulose, Cellulose Ethers, and Carboxymethylcellulose and Croscarmellose Sodium. The Microcrystalline Cellulose segment is projected to expand at a CAGR of 5.7% during 2026 - 2034.
• By Starches For Type, the South and Central America Pharmaceutical Excipients Market is segmented into Modified Starches, Dried Starch, and Converted Starch and Pregelatinized Starch. The Modified Starches segment is projected to expand at a CAGR of 4.1% during 2026 - 2034.
• By Petrochemicals For Type, the South and Central America Pharmaceutical Excipients Market is segmented into Glycols, Povidones, Mineral Hydrocarbons, and Other Petrochemicals. The Glycols segment is projected to expand at a CAGR of 5.6% during 2026 - 2034.
• By Inorganic Chemicals For Type, the South and Central America Pharmaceutical Excipients Market is segmented into Magnesium and Calcium Carbonate, Calcium and Aluminum Phosphate, Silicon Dioxide, Titanium Dioxide, and Other Inorganic Chemicals. The Calcium and Aluminum Phosphate segment is projected to expand at a CAGR of 7.2% during 2026 - 2034.
• By Clinical Indication, the South and Central America Pharmaceutical Excipients Market is segmented into Cancer, Metabolic, Infectious Disease, Dental, Ophthalmic, Cardiovascular, and Other Clinical Indications. The Cancer segment is projected to expand at a CAGR of 6.6% during 2026 - 2034.
• By Functionality, the South and Central America Pharmaceutical Excipients Market is segmented into Coloring Agents and Coating Agents, Sweetner and Flavoring Agents, Suspending and Viscosity Agents, Preservative and Controlled Release, Antioxidant and Oil, Tablet Filler and Diluent, Binder and Compression and Granulating Agents, Emulsifiers, Surfactants, and Others. The Tablet Filler and Diluent segment is projected to expand at a CAGR of 5.5% during 2026 - 2034.
• By Surfactants For Functionality, the South and Central America Pharmaceutical Excipients Market is segmented into Polyoxyethylene Hydrogenated Castor Oil, Polysorbates, Sodium Dodecyl Sulfate, and Other Surfactants. The Polysorbates segment is projected to expand at a CAGR of 6.9% during 2026 - 2034.
• By Application, the South and Central America Pharmaceutical Excipients Market is segmented into Oral, Injectable, Topical, and Others. The Oral segment is projected to expand at a CAGR of 6.0% during 2026 - 2034.
• By Oral For Application, the South and Central America Pharmaceutical Excipients Market is segmented into Tablet, Capsule, Liquid, and Others. The Tablet segment is projected to expand at a CAGR of 6.5% during 2026 - 2034.
• By Capsule For Oral, the South and Central America Pharmaceutical Excipients Market is segmented into Hard Gel and Soft Gel. The Hard Gel segment is projected to expand at a CAGR of 6.0% during 2026 - 2034.
• By End User, the South and Central America Pharmaceutical Excipients Market is segmented into Pharma Industries, Biopharma Industries, Animal Health, and Other End User. The Pharma Industries segment is projected to expand at a CAGR of 5.9% during 2026 - 2034.

By country, the South and Central America Pharmaceutical Excipients Market is categorized into Brazil, Argentina, and the Rest of South and Central America. Brazil is projected to expand at a CAGR of 6.2% during 2026 - 2034.

Key players operating in the Pharmaceutical Excipients Market are BASF SE, JRS PHARMA GmbH & Co KG, Roquette Freres SA, Avantor Inc, Archer-Daniels-Midland Co, Evonik Industries AG, Merck KGaA, The Dow Chemical Co, The Lubrizol Corp, Ashland Inc, and MEGGLE GmbH & Co KG, among others.

• In May 2024,  Roquette announced the launch of its new LYCAGEL Flex hydroxypropyl pea starch premix for nutraceutical and pharmaceutical softgel capsules. Built on Roquette's market-first LYCAGEL pea starch technology, the new plasticizer-free excipient gives manufacturers freedom to select the optimal plasticizer combination and customize formulations for a range of production and end-user needs, while setting new standards in quality, stability and performance for plant-based softgels.